YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG: 1558)

YiChang HEC ChangJiang Pharmaceutical Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 13, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	8,448	8,351	5,720	5,368	7,770	19,686
Market Cap Growth	38.85%	46.00%	6.56%	-30.92%	-60.53%	66.87%
Enterprise Value	9,325	9,299	9,130	7,738	7,962	19,877
Last Close Price	9.60	9.49	6.50	6.10	8.83	21.62
PE Ratio	4.78	3.81	66.05	-7.42	13.93	9.35
PS Ratio	1.42	1.20	1.35	4.79	2.79	2.83
PB Ratio	0.91	0.96	0.83	0.73	1.28	3.81
P/FCF Ratio	-99.71	5.70	4.48	-4.29	21.43	14.45
P/OCF Ratio	17.00	4.53	2.98	-6.60	5.03	9.81
EV/Sales Ratio	1.57	1.34	2.16	6.90	2.86	2.85
EV/EBITDA Ratio	3.43	2.66	11.68	-30.52	7.06	6.80
EV/EBIT Ratio	4.06	3.03	25.02	-13.76	8.04	7.02
EV/FCF Ratio	-112.40	6.35	7.15	-6.19	21.96	14.59
Debt / Equity Ratio	0.27	0.33	0.63	0.53	0.59	0.66
Debt / EBITDA Ratio	0.92	0.82	5.46	-	3.15	1.16
Debt / FCF Ratio	-30.30	1.96	3.38	-3.13	9.86	2.49
Asset Turnover	0.43	0.51	0.33	0.09	0.24	0.86
Inventory Turnover	2.50	3.62	3.02	1.31	1.20	4.58
Quick Ratio	1.34	0.88	0.46	1.36	0.64	2.22
Current Ratio	2.15	1.40	1.01	1.66	0.78	2.31
Return on Equity (ROE)	19.25%	26.50%	0.81%	-10.57%	17.22%	45.94%
Return on Assets (ROA)	10.30%	14.16%	1.80%	-2.85%	5.35%	21.85%
Return on Capital (ROIC)	11.83%	17.07%	2.11%	-3.30%	6.61%	27.76%
Earnings Yield	21.41%	26.29%	1.51%	-13.44%	12.83%	10.90%
FCF Yield	-1.00%	17.54%	22.33%	-23.30%	4.67%	6.92%
Dividend Yield	0.00%	-	-	-	1.34%	3.36%
Payout Ratio	0.00%	-	-	-	26.21%	37.53%
Buyback Yield / Dilution	-	-	20.42%	-9.51%	-11.69%
Total Shareholder Return	-	-	20.42%	-8.17%	-8.33%

Source: S&P Capital IQ. Standard template. Financial Sources.